PTP4A3 and hepatocellular carcinoma: Celecoxib, a promising candidate for anticancer therapy, upregulates PTEN protein expression in mouse hepatoma tissues while downregulating NF-κB and PRL-3 protein expression, ultimately attenuating liver cell proliferation [87].